|
2005 Journal Article Steatosis: Co-factor in other liver diseasesPowell, EE, Jonsson, JR and Clouston, AD (2005). Steatosis: Co-factor in other liver diseases. Hepatology, 42 (1), 5-13. doi: 10.1002/hep.20750 |
|
2005 Journal Article Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver diseasePowell, EE, Jonsson, JR and Clouston, AD (2005). Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver disease. Annals of Internal Medicine, 143 (10), 753-754. doi: 10.7326/0003-4819-143-10-200511150-00015 |
|
2004 Journal Article Nonalcoholic fatty liver disease: is all the fat bad?Clouston, A. D. and Powell, E. E. (2004). Nonalcoholic fatty liver disease: is all the fat bad?. Internal Medicine Journal, 34 (4), 187-191. doi: 10.1111/j.1444-0903.2004.00574.x |
|
2004 Journal Article Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejectionJonsson, Julie R., Gu, Wenyi, Vanags, Daina M., Bishop, G. Alex, McCaughan, Geoffrey W., Fawcett, Jonathon, Lynch, Stephen V., Balderson, Glenda A., Powell, Elizabeth E. and Clouston, Andrew D. (2004). Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transplantation, 10 (3), 397-403. doi: 10.1002/lt.20084 |
|
2004 Journal Article An approach to the surgical pathology of tumours and tumour-like conditions of the liverClouston, A (2004). An approach to the surgical pathology of tumours and tumour-like conditions of the liver. Pathology, 36 (1), 5-18. doi: 10.1080/00313020310001648413 |
|
2004 Journal Article Virus-specific CD8+ T lymphocytes within the normal human liverWard, S. M., Jonsson, J. R., Sierro, S., Clouston, A. D., Lucas, M., Vargas, A. L., Powell, E. E. and Klenerman, P. (2004). Virus-specific CD8+ T lymphocytes within the normal human liver. European Journal of Immunology, 34 (6), 1526-1531. doi: 10.1002/eji.200324275 |
|
2004 Journal Article CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitisEri, R, Jonsson, JR, Pandeya, N, Purdie, DM, Clouston, AD, Martin, N, Duffy, D, Powell, EE, Fawcett, J, Florin, THJ and Radford-Smith, GL (2004). CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitis. Genes And Immunity, 5 (6), 444-450. doi: 10.1038/sj.gene.6364113 |
|
2004 Journal Article Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of lifeHickman, IJ, Jonsson, JR, Prins, JB, Ash, S, Purdie, DM, Clouston, AD and Powell, EE (2004). Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut, 53 (3), 413-419. doi: 10.1136/gut.2003.027581 |
|
2004 Journal Article Chronic hepatitis C and steatosisClouston, A. D., Jonsson, J. R. and Powell, E. (2004). Chronic hepatitis C and steatosis. Current Hepatitis Reports, 3 (4), 123-128. |
|
2004 Journal Article Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: The role of donor T-cell dose and differentiationMacDonald, Kelli P. A., Rowe, Vanessa, Filippich, Cheryl, Johnson, Diana, Morris, Edward S., Clouston, Andrew D., Ferrara, James L. M. and Hill, Geoffrey R. (2004). Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: The role of donor T-cell dose and differentiation. Biology of Blood And Marrow Transplantation, 10 (6), 373-385. doi: 10.1016/j.bbmt.2004.02.002 |
|
2004 Conference Publication Factors affecting the gene expression of hepcidin in chronic viral hepatitis CBridle, K. R., Fletcher, L. M., Jonsson, J. R., Richardson, M. M., Clouston, A. D., Powell, E. E. and Crawford, D. H. G. (2004). Factors affecting the gene expression of hepcidin in chronic viral hepatitis C. Australian Gastroenterology Week 2004, Brisbane Convention Centre, Brisbane, Qld Australia, 4-8 October, 2004. Carlton South, Vic. Australia: Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2004.3615_3..x |
|
2004 Conference Publication Donor treatment with pegylated-G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant toleranceMorris, E., MacDonald, K., Rowe, V., Johnson, D., Banovic, T., Clouston, A. and Hill, G. (2004). Donor treatment with pegylated-G-CSF augments the generation of IL-10 producing regulatory T cells and promotes transplant tolerance. 22nd Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, 31 March - 2 April 2004 . Basingstoke, U.K.: Nature Publishing Group. |
|
2004 Journal Article Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injuryWalsh, MJ, Vanags, DM, Clouston, AD, Richardson, MM, Purdie, DM, Jonsson, JR and Powell, EE (2004). Steatosis and liver cell apoptosis in chronic hepatitis C: A mechanism for increased liver injury. Hepatology, 39 (5), 1230-1238. doi: 10.1002/hep.20179 |
|
2004 Journal Article Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation toleranceMorris, ES, MacDonald, KPA, Rowe, V, Johnson, DH, Banovic, T, Clouston, AD and Hill, GR (2004). Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood, 103 (9), 3573-3581. doi: 10.1182/blood-2003-08-2864 |
|
2003 Journal Article In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapyHickman, I. J., Powell, E. E., Prins, J. B., Clouston, A. D., Ash, S., Purdie, D. M. and Jonsson, J. R. (2003). In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. Journal of Hepatology, 39 (6), 1042-1048. doi: 10.1016/S0168-8278(03)00463-X |
|
2003 Conference Publication Donor treatment with peg-G-CSF induces profound transplant tolerance due to the generation of IL-10 producing regulatory T cells.Morris, ES, MacDonald, KP, Rowe, V, Johnson, DH, Banovic, T, Clouston, AD and Hill, GR (2003). Donor treatment with peg-G-CSF induces profound transplant tolerance due to the generation of IL-10 producing regulatory T cells.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: BLACKWELL PUBLISHING ASIA. |
|
2003 Journal Article Tumor progression in hepatocellular carcinoma: Relationship with tumor stroma and parenchymal diseaseLockwood, D. S. R, Yeadon, T. M., Clouston, A. D., Crawford, D. G., Fawcett, J., Callaghan, S. A. and Gotley, D. C. (2003). Tumor progression in hepatocellular carcinoma: Relationship with tumor stroma and parenchymal disease. Journal of Gastroenterology And Hepatology, 18 (6), 666-672. doi: 10.1046/j.1440-1746.2003.03018.x |
|
2003 Journal Article Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantationMacDonald, Kelli P. A., Rowe, Vanessa, Filippich, Cheryl, Thomas, Ranjeny, Clouston, Andrew D., Welply, Joseph K., Hart, Derek N. J., Ferrara, James L. M. and Hill, Geoffrey R. (2003). Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood, 101 (5), 2033-2042. doi: 10.1182/blood-2002-05-1529 |
|
2003 Conference Publication Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerismClouston, A., Vanags, D. M., Gu, W. Y., Powell, E. E. and Jonsson, J. R. (2003). Absence of rejection after human liver orthotopic liver transplantation (OLT) is associated with leukocyte apoptosis, increased lymphocyte activation and higher donor cell chimerism. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons. |
|
2003 Conference Publication Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progressionClouston, A. D., Jonsson, J. R., Letizia, B., Richardson, M. M., Vanags, D. M., Walsh, M., Demetris, A. J. and Powell, E. E. (2003). Fibrosis in chronic hepatitis C is associated with hepatic progenitor cell proliferation and a periportal ductular reaction, which is exacerbated by steatosis: A new model for disease progression. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, Boston, MA, United States, 24-28 October 2003. Hoboken, NJ, United States: John Wiley & Sons. |
